545 related articles for article (PubMed ID: 31698775)
1. Pivotal Role of STAT3 in Shaping Glioblastoma Immune Microenvironment.
Piperi C; Papavassiliou KA; Papavassiliou AG
Cells; 2019 Nov; 8(11):. PubMed ID: 31698775
[TBL] [Abstract][Full Text] [Related]
2. Insights in the immunobiology of glioblastoma.
Strepkos D; Markouli M; Klonou A; Piperi C; Papavassiliou AG
J Mol Med (Berl); 2020 Jan; 98(1):1-10. PubMed ID: 31650201
[TBL] [Abstract][Full Text] [Related]
3. The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment.
Chang N; Ahn SH; Kong DS; Lee HW; Nam DH
Mol Cell Endocrinol; 2017 Aug; 451():53-65. PubMed ID: 28089821
[TBL] [Abstract][Full Text] [Related]
4. Single-Cell RNA-Sequencing Shift in the Interaction Pattern Between Glioma Stem Cells and Immune Cells During Tumorigenesis.
Zhai Y; Li G; Li R; Chang Y; Feng Y; Wang D; Wu F; Zhang W
Front Immunol; 2020; 11():581209. PubMed ID: 33133100
[TBL] [Abstract][Full Text] [Related]
5. SH3BGRL3, transcribed by STAT3, facilitates glioblastoma tumorigenesis by activating STAT3 signaling.
Nie Z; Cheng D; Pan C; Wei Z; Wang C; Wang C
Biochem Biophys Res Commun; 2021 Jun; 556():114-120. PubMed ID: 33839406
[TBL] [Abstract][Full Text] [Related]
6. OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy.
Shibahara I; Saito R; Zhang R; Chonan M; Shoji T; Kanamori M; Sonoda Y; Kumabe T; Kanehira M; Kikuchi T; So T; Watanabe T; Takahashi H; Iwabuchi E; Tanaka Y; Shibahara Y; Sasano H; Ishii N; Tominaga T
Mol Cancer; 2015 Feb; 14():41. PubMed ID: 25744203
[TBL] [Abstract][Full Text] [Related]
7. Role of STAT3 in Genesis and Progression of Human Malignant Gliomas.
Ouédraogo ZG; Biau J; Kemeny JL; Morel L; Verrelle P; Chautard E
Mol Neurobiol; 2017 Oct; 54(8):5780-5797. PubMed ID: 27660268
[TBL] [Abstract][Full Text] [Related]
8. The Dynamics of Interactions Among Immune and Glioblastoma Cells.
Eder K; Kalman B
Neuromolecular Med; 2015 Dec; 17(4):335-52. PubMed ID: 26224516
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of tumor-immune symbiosis in glioma.
Liu Y; Ali H; Khan F; Pang L; Chen P
Trends Mol Med; 2024 May; 30(5):429-442. PubMed ID: 38453529
[TBL] [Abstract][Full Text] [Related]
10. Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators.
Lo HW; Cao X; Zhu H; Ali-Osman F
Clin Cancer Res; 2008 Oct; 14(19):6042-54. PubMed ID: 18829483
[TBL] [Abstract][Full Text] [Related]
11. Loss of SH3GL2 promotes the migration and invasion behaviours of glioblastoma cells through activating the STAT3/MMP2 signalling.
Zhu Y; Zhang X; Wang L; Ji Z; Xie M; Zhou X; Liu Z; Shi H; Yu R
J Cell Mol Med; 2017 Nov; 21(11):2685-2694. PubMed ID: 28470949
[TBL] [Abstract][Full Text] [Related]
12. The interplay between glioblastoma and microglia cells leads to endothelial cell monolayer dysfunction via the interleukin-6-induced JAK2/STAT3 pathway.
Couto M; Coelho-Santos V; Santos L; Fontes-Ribeiro C; Silva AP; Gomes CMF
J Cell Physiol; 2019 Nov; 234(11):19750-19760. PubMed ID: 30937892
[TBL] [Abstract][Full Text] [Related]
13. A tumor-targeting nanomedicine carrying the p53 gene crosses the blood-brain barrier and enhances anti-PD-1 immunotherapy in mouse models of glioblastoma.
Kim SS; Harford JB; Moghe M; Slaughter T; Doherty C; Chang EH
Int J Cancer; 2019 Nov; 145(9):2535-2546. PubMed ID: 31241175
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy.
Kamran N; Kadiyala P; Saxena M; Candolfi M; Li Y; Moreno-Ayala MA; Raja N; Shah D; Lowenstein PR; Castro MG
Mol Ther; 2017 Jan; 25(1):232-248. PubMed ID: 28129117
[TBL] [Abstract][Full Text] [Related]
15. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
[TBL] [Abstract][Full Text] [Related]
16. Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma.
DeCordova S; Shastri A; Tsolaki AG; Yasmin H; Klein L; Singh SK; Kishore U
Front Immunol; 2020; 11():1402. PubMed ID: 32765498
[TBL] [Abstract][Full Text] [Related]
17. Immune Cytolytic Activity Is Associated With Genetic and Clinical Properties of Glioma.
Wang ZL; Wang Z; Li GZ; Wang QW; Bao ZS; Zhang CB; Jiang T
Front Immunol; 2019; 10():1756. PubMed ID: 31428092
[No Abstract] [Full Text] [Related]
18. Signal transducer and activator of transcription 1 (Stat1) maintains basal mRNA expression of pro-survival stat3-target genes in glioma C6 cells.
Adach-Kilon A; Swiatek-Machado K; Kaminska B; Dabrowski M
J Cell Biochem; 2011 Dec; 112(12):3685-94. PubMed ID: 21815198
[TBL] [Abstract][Full Text] [Related]
19. NFAT1-Mediated Regulation of NDEL1 Promotes Growth and Invasion of Glioma Stem-like Cells.
Jiang Y; Song Y; Wang R; Hu T; Zhang D; Wang Z; Tie X; Wang M; Han S
Cancer Res; 2019 May; 79(10):2593-2603. PubMed ID: 30940662
[TBL] [Abstract][Full Text] [Related]
20. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y
J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
